Literature DB >> 8043956

The mouse mutant Polydactyly Nagoya (Pdn) defines a novel allele of the zinc finger gene Gli3.

T Schimmang1, S I Oda, U Rüther.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8043956     DOI： 10.1007/bf00356560

Source DB:  PubMed          Journal:  Mamm Genome        ISSN： 0938-8990            Impact factor:   2.957


× No keyword cloud information.
  22 in total

1.  GLI3 encodes a 190-kilodalton protein with multiple regions of GLI similarity.

Authors:  J M Ruppert; B Vogelstein; K Arheden; K W Kinzler
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

Review 2.  Pax in development.

Authors:  P Gruss; C Walther
Journal:  Cell       Date:  1992-05-29       Impact factor: 41.582

3.  Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3.

Authors:  D J Epstein; M Vekemans; P Gros
Journal:  Cell       Date:  1991-11-15       Impact factor: 41.582

4.  Deletion of GLI3 supports the homology of the human Greig cephalopolysyndactyly syndrome (GCPS) and the mouse mutant extra toes (Xt).

Authors:  A Vortkamp; T Franz; M Gessler; K H Grzeschik
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

5.  A mouse model of greig cephalopolysyndactyly syndrome: the extra-toesJ mutation contains an intragenic deletion of the Gli3 gene.

Authors:  C C Hui; A L Joyner
Journal:  Nat Genet       Date:  1993-03       Impact factor: 38.330

6.  Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene.

Authors:  M Tassabehji; A P Read; V E Newton; R Harris; R Balling; P Gruss; T Strachan
Journal:  Nature       Date:  1992-02-13       Impact factor: 49.962

7.  An exonic mutation in the HuP2 paired domain gene causes Waardenburg's syndrome.

Authors:  C T Baldwin; C F Hoth; J A Amos; E O da-Silva; A Milunsky
Journal:  Nature       Date:  1992-02-13       Impact factor: 49.962

8.  Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I).

Authors:  C F Hoth; A Milunsky; N Lipsky; R Sheffer; S K Clarren; C T Baldwin
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

9.  Greig cephalopolysyndactyly syndrome: a possible mouse homologue (Xt-extra toes).

Authors:  R M Winter; S M Huson
Journal:  Am J Med Genet       Date:  1988-12

10.  Evidence for allelism of the recessive insertional mutation add and the dominant mouse mutation extra-toes (Xt).

Authors:  T M Pohl; M G Mattei; U Rüther
Journal:  Development       Date:  1990-12       Impact factor: 6.868
View more
  4 in total

1.  The phenotypic spectrum of GLI3 morphopathies includes autosomal dominant preaxial polydactyly type-IV and postaxial polydactyly type-A/B; No phenotype prediction from the position of GLI3 mutations.

Authors:  U Radhakrishna; D Bornholdt; H S Scott; U C Patel; C Rossier; H Engel; A Bottani; D Chandal; J L Blouin; J V Solanki; K H Grzeschik; S E Antonarakis
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

2.  Human intronic enhancers control distinct sub-domains of Gli3 expression during mouse CNS and limb development.

Authors:  Amir A Abbasi; Zissis Paparidis; Sajid Malik; Fiona Bangs; Ansgar Schmidt; Sabine Koch; Javier Lopez-Rios; Karl-Heinz Grzeschik
Journal:  BMC Dev Biol       Date:  2010-04-28       Impact factor: 1.978

3.  Identification and functional characterization of novel transcriptional enhancers involved in regulating human GLI3 expression during early development.

Authors:  Saneela Anwar; Rashid Minhas; Shahid Ali; Nicholas Lambert; Yasuhiko Kawakami; Greg Elgar; Syed Sikandar Azam; Amir Ali Abbasi
Journal:  Dev Growth Differ       Date:  2015-10-14       Impact factor: 2.053

4.  Human GLI3 intragenic conserved non-coding sequences are tissue-specific enhancers.

Authors:  Amir Ali Abbasi; Zissis Paparidis; Sajid Malik; Debbie K Goode; Heather Callaway; Greg Elgar; Karl-Heinz Grzeschik
Journal:  PLoS One       Date:  2007-04-11       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.